EP1224201A4 - 32 proteines humaines secretees - Google Patents
32 proteines humaines secreteesInfo
- Publication number
- EP1224201A4 EP1224201A4 EP00975362A EP00975362A EP1224201A4 EP 1224201 A4 EP1224201 A4 EP 1224201A4 EP 00975362 A EP00975362 A EP 00975362A EP 00975362 A EP00975362 A EP 00975362A EP 1224201 A4 EP1224201 A4 EP 1224201A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16223999P | 1999-10-29 | 1999-10-29 | |
US162239P | 1999-10-29 | ||
US21513900P | 2000-06-30 | 2000-06-30 | |
US215139P | 2000-06-30 | ||
PCT/US2000/029363 WO2001032675A1 (fr) | 1999-10-29 | 2000-10-25 | 32 proteines humaines secretees |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1224201A1 EP1224201A1 (fr) | 2002-07-24 |
EP1224201A4 true EP1224201A4 (fr) | 2005-03-02 |
Family
ID=26858568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00975362A Withdrawn EP1224201A4 (fr) | 1999-10-29 | 2000-10-25 | 32 proteines humaines secretees |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1224201A4 (fr) |
JP (1) | JP2003528586A (fr) |
AU (1) | AU1342501A (fr) |
CA (1) | CA2386641A1 (fr) |
WO (1) | WO2001032675A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7112655B1 (en) | 1997-02-27 | 2006-09-26 | Japan Tobacco, Inc. | JTT-1 protein and methods of inhibiting lymphocyte activation |
JP3521382B2 (ja) | 1997-02-27 | 2004-04-19 | 日本たばこ産業株式会社 | 細胞間接着及びシグナル伝達を媒介する細胞表面分子 |
JP4210454B2 (ja) | 2001-03-27 | 2009-01-21 | 日本たばこ産業株式会社 | 炎症性腸疾患治療剤 |
JP3871503B2 (ja) | 1999-08-30 | 2007-01-24 | 日本たばこ産業株式会社 | 免疫性疾患治療剤 |
JP3597140B2 (ja) | 2000-05-18 | 2004-12-02 | 日本たばこ産業株式会社 | 副刺激伝達分子ailimに対するヒトモノクローナル抗体及びその医薬用途 |
WO2002074803A2 (fr) * | 2001-01-16 | 2002-09-26 | Bayer Aktiengesellschaft | Regulation de la proteine v des co-stimulateurs inductibles (icos) humains |
EP1368468A4 (fr) * | 2001-02-23 | 2005-02-16 | Human Genome Sciences Inc | 83 proteines humaines secretes |
JP4212278B2 (ja) | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
GB0224436D0 (en) * | 2002-10-21 | 2002-11-27 | Univ Cambridge Tech | Polypetides methods and means |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998001552A2 (fr) * | 1996-07-09 | 1998-01-15 | Genetics Institute, Inc. | Proteines secretees et polynucleotides codant lesdites proteines |
WO1999047540A1 (fr) * | 1998-03-19 | 1999-09-23 | Human Genome Sciences, Inc. | 95 proteines humaines secretees |
WO2000012708A2 (fr) * | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Nouveaux pro-polypeptides et sequences correspondantes |
WO2000053750A1 (fr) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions et procedes pour le traitement de tumeurs |
WO2000078961A1 (fr) * | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
EP1067182A2 (fr) * | 1999-07-08 | 2001-01-10 | Helix Research Institute | Proteine secretoire ou proteine de membrane |
WO2001018016A1 (fr) * | 1999-09-10 | 2001-03-15 | Millennium Pharmaceuticals, Inc. | Nouveaux genes codant pour des proteines a usages previsionnel, diagnostique therapeutique et autres |
-
2000
- 2000-10-25 JP JP2001535376A patent/JP2003528586A/ja not_active Withdrawn
- 2000-10-25 CA CA002386641A patent/CA2386641A1/fr not_active Abandoned
- 2000-10-25 EP EP00975362A patent/EP1224201A4/fr not_active Withdrawn
- 2000-10-25 AU AU13425/01A patent/AU1342501A/en not_active Abandoned
- 2000-10-25 WO PCT/US2000/029363 patent/WO2001032675A1/fr not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998001552A2 (fr) * | 1996-07-09 | 1998-01-15 | Genetics Institute, Inc. | Proteines secretees et polynucleotides codant lesdites proteines |
WO1999047540A1 (fr) * | 1998-03-19 | 1999-09-23 | Human Genome Sciences, Inc. | 95 proteines humaines secretees |
WO2000012708A2 (fr) * | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Nouveaux pro-polypeptides et sequences correspondantes |
WO2000053750A1 (fr) * | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions et procedes pour le traitement de tumeurs |
WO2000078961A1 (fr) * | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
EP1067182A2 (fr) * | 1999-07-08 | 2001-01-10 | Helix Research Institute | Proteine secretoire ou proteine de membrane |
WO2001018016A1 (fr) * | 1999-09-10 | 2001-03-15 | Millennium Pharmaceuticals, Inc. | Nouveaux genes codant pour des proteines a usages previsionnel, diagnostique therapeutique et autres |
Non-Patent Citations (4)
Title |
---|
CELIS J E ET AL: "SECRETED PROTEINS FROM NORMAL AND SV40 TRANSFORMED HUMAN MRC-5 FIBROBLASTS: TOWARD ESTABLISHING A DATABASE OF HUMAN SECRETED PROTEINS", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 1, no. 10, October 1987 (1987-10-01), pages 707 - 717, XP001118789, ISSN: 0887-6924 * |
DATABASE EMBL EMBL; 30 August 1999 (1999-08-30), KOEHRER ET AL, XP002298528, retrieved from EBI accession no. HSM800846 Database accession no. AL110276 * |
LANGER-SAFER P R ET AL: "STRATEGIES FOR THE APPLICATION OF FUNCTIONAL GENOMICS TECHNOLOGY TO BIOPHARMACEUTICAL DRUG DISCOVERY", DRUG DEVELOPMENT RESEARCH, NEW YORK, NY, US, vol. 41, no. 3/4, July 1997 (1997-07-01), pages 173 - 179, XP001117948, ISSN: 0272-4391 * |
See also references of WO0132675A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU1342501A (en) | 2001-05-14 |
JP2003528586A (ja) | 2003-09-30 |
WO2001032675A1 (fr) | 2001-05-10 |
CA2386641A1 (fr) | 2001-05-10 |
EP1224201A1 (fr) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1218408A4 (fr) | 32 proteines humaines secretees | |
EP1212343A4 (fr) | 52 proteines humaines secretees | |
EP1181390A4 (fr) | 27 proteines humaines secretees | |
EP1224285A4 (fr) | 27 proteines humaines secretees | |
EP1212342A4 (fr) | 18 proteines secretees humaines | |
EP1226231A4 (fr) | 19 proteines humaines secretees | |
EP1175438A4 (fr) | Soixante-deux prot ines humaines s cr t es | |
EP1192278A4 (fr) | 48 proteines secretees humaines | |
EP1192176A4 (fr) | 49 proteines secretees humaines | |
EP1165827A4 (fr) | 45 proteines humaines secretees | |
EP1175439A4 (fr) | 49 proteines humaines secretees | |
EP1159284A4 (fr) | 33 proteines humaines secretees | |
EP1189917A4 (fr) | 48 proteines humaines secretees | |
EP1185543A4 (fr) | 50 proteines humaines secretees | |
EP1173477A4 (fr) | 49 proteines humaines secretees | |
EP1224201A4 (fr) | 32 proteines humaines secretees | |
EP1203005A4 (fr) | 25 proteines secretees humaines | |
EP1206573A4 (fr) | 26 proteines humaines secretees | |
EP1169332A4 (fr) | Proteines humaines secretees (49) | |
EP1171460A4 (fr) | 48 proteines secretees humaines | |
EP1165602A4 (fr) | 49 proteines secretees par un etre humain | |
EP1144614A4 (fr) | Proteines humaines secretees (33) | |
EP1165828A4 (fr) | 50 proteines humaines secretees | |
EP1228082A4 (fr) | Proteines humaines secretees 29 | |
EP1185285A4 (fr) | 49 proteines secretees humaines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020508 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HUMAN GENOME SCIENCES, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050113 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051119 |